297 related articles for article (PubMed ID: 33175835)
1. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
Pasaribu AP; Chokejindachai W; Sirivichayakul C; Tanomsing N; Chavez I; Tjitra E; Pasaribu S; Imwong M; White NJ; Dondorp AM
J Infect Dis; 2013 Dec; 208(11):1906-13. PubMed ID: 23926329
[TBL] [Abstract][Full Text] [Related]
3. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
Douglas NM; Poespoprodjo JR; Patriani D; Malloy MJ; Kenangalem E; Sugiarto P; Simpson JA; Soenarto Y; Anstey NM; Price RN
PLoS Med; 2017 Aug; 14(8):e1002379. PubMed ID: 28850568
[TBL] [Abstract][Full Text] [Related]
4. Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
Setyadi A; Arguni E; Kenangalem E; Hasanuddin A; Lampah DA; Thriemer K; Anstey NM; Sugiarto P; Simpson JA; Price RN; Douglas NM; Poespoprodjo JR
Malar J; 2019 Apr; 18(1):111. PubMed ID: 30940140
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
6. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
[TBL] [Abstract][Full Text] [Related]
8. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
9. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
[TBL] [Abstract][Full Text] [Related]
11. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
13. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
14. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Chu CS; Douglas NM; Abreha T; Alemu SG; Añez A; Anstey NM; Aseffa A; Assefa A; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Grigg MJ; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Taylor WRJ; Thwaites G; Tran BQ; Hien TT; Vieira JLF; Wangchuk S; Watson J; William T; Woodrow CJ; Nosten F; Guerin PJ; White NJ; Price RN
BMC Med; 2019 Aug; 17(1):151. PubMed ID: 31366382
[TBL] [Abstract][Full Text] [Related]
15. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M; Simpson JA; Ley B; Edler P; Chu CS; Abreha T; Awab GR; Baird JK; Bancone G; Barber BE; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Saravu K; Sutanto I; Taylor WRJ; Thriemer K; Watson JA; Guerin PJ; White NJ; Price RN; Commons RJ;
Lancet Infect Dis; 2024 Feb; 24(2):184-195. PubMed ID: 37748497
[TBL] [Abstract][Full Text] [Related]
16. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
17. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
18. Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
Hamid MMA; Thriemer K; Elobied ME; Mahgoub NS; Boshara SA; Elsafi HMH; Gumaa SA; Hamid T; Abdelbagi H; Basheir HM; Marfurt J; Chen I; Gosling R; Price RN; Ley B
Malar J; 2018 Mar; 17(1):117. PubMed ID: 29548285
[TBL] [Abstract][Full Text] [Related]
19. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
20. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
